VOLTAGE: Multicenter phase Ib/II study of nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy (CRT) with capecitabine in patients with locally advanced rectal cancer (LARC)
Hideaki Bando(Aichi Cancer Center), Takayuki Yoshino(University of Tsukuba), Yuichiro Tsukada(National Cancer Center Hospital East), Mamoru Uemura(Osaka International Cancer Institute), Takeshi Sasaki(Sapporo Medical University), Hiroyoshi Nishikawa(Immunité et Cancer), Yuji Nishizawa(National Cancer Center Hospital East), Yosuke Togashi(Okayama University), Shigenori Homma(Hokkaido University), Yoshito Komatsu(Hokkaido University Hospital), Masashi Wakabayashi(Japan Clinical Cancer Research Organization), Masaaki Ito(National Cancer Centre Japan), Akihiro Sato(Yokohama Municipal Citizen's Hospital), Yoshihiro Matsuno(Hokkaido University Hospital), Motohiro Kojima(Chiba Cancer Center), Yutaka Hatanaka(Hokkaido University), Takeshi Kato(Osaka National Hospital), Shota Fukuoka(National Cancer Research Institute), Satoshi Yuki(Hokkaido University Hospital), Koji Inamori(National Cancer Center Hospital East)
Cited by 4
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
|The Lancet|2022|1.6k
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k